(By Julie Appleby and Sydney Lupkin for Kaiser Health News)
President Donald Trump wants to control spending on drugs. One of his big ideas: include prices in advertisements, just like warnings about side effects.
That’s not as simple as it sounds.
Apart from legal questions about whether the Food and Drug Administration has the authority to require pricing in ads, other uncertainties arise. Continue reading article here…
Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.